WiFiMed Holdings Company Chief Executive Officer Provides Update in Special Letter to Shareholders

ATLANTA--(BUSINESS WIRE)--WiFiMed Holdings Company, Inc. (“WiFiMed Holdings”) (OTCBB:WIFM), whose holdings are leading providers of physician workflow solutions, announced today that its Chief Executive Officer, Gregory Vacca, has issued a Special Letter to Shareholders to update investors on the current status of the Company, and more importantly, management’s perspective on the Company’s future growth outlook. The text from the letter follows:

Dear Shareholder,

I’m pleased to be writing my first special letter to you as Chief Executive Officer of WiFiMed Holdings Company, Inc. (OTCBB:WIFM) updating you on recent events and future growth plans for the Company. Marshall Sterman, Chairman of the Board of WiFiMed Holdings joins me in sending you this letter.

Much has happened over the last year to help build value for our shareholders and much more is expected to come in 2008 and beyond. We are aggressively pursuing our main growth strategy of significant market penetration through major acquisitions of key technologies and companies complementary to the current product offerings of WiFiMed Holdings’ subsidiary companies, and have achieved some significant milestones which I will share with you here.

I want to start by discussing some of our most recent announcements regarding acquisitions. In October 2007 we announced the acquisition of all the major assets of JMJ Technologies, Inc. and created our second wholly-owned subsidiary, Encounter PRO Healthcare Resources, Inc. EncounterPRO Healthcare Resources, Inc. provides EncounterPRO^® EHR 5.0, the latest version of the electronic health record software which is CCHIT certified for Ambulatory Care 2006 and has been enthusiastically adopted by physicians because it meets their specialized needs for technically advanced information systems. The EncounterPRO EHR has a proven track record of substantially increasing efficiency, productivity and quality of care while reducing costs and improving cash flow. The EncounterPRO EHR has been on the market for over twelve years and supports over 300 practices with over 1,000 providers and over 3 million patients. It has won numerous prestigious awards in the industry and is in use in 32 states and two foreign countries. This acquisition adds well over $2 million to our current revenue stream with substantial growth anticipated in the future.

Additionally, we have recently purchased the assets of CyberMedx Medical Systems, LLC, developer of the InteleNett™ family of wireless patient data management products for the hospital industry and the Cyber Medical Exchange (C_ME™) family of internet-based telemonitoring device data management products for the home care and nursing home industries. Finally, on January 29, 2008 we announced signing a Letter of Intent to acquire an established specialty pharmacy services company with a solid 23-year history. This particular company has evolved as a premier provider of niche pharmacy prescription services and home healthcare services, including a critical care home ventilator program, oxygen, enteral therapy, durable medical equipment and disposable medical supplies. With a compounded annual growth rate (CAGR) of over 15% for the last four years, this proposed WiFiMed Holdings acquisition is expected to add nearly $15 million to the company’s revenues in the first year following the anticipated closing. In addition to these, we are continuing to identify and target other potential companies that offer products complementary to our current offerings that will help grow the Company; we expect to announce a number of additional accretive acquisition targets in 2008.

To help spearhead the current and future acquisitions and raise the needed capital to complete them, we have engaged the services of Archer Capital, Inc. to provide investment banking and advisory services. Archer Capital served as the lead advisor in the acquisition of JMJ Technologies core operating assets as well as the CyberMedx asset acquisition. Their involvement provides us with a valuable relationship and access to a vast network of institutional investors to help finance all our short term acquisitions in a timely manner.

In order to grasp fully the importance of these acquisitions, it’s important to understand the market and the opportunity that we have within it. Medical practices are experiencing many financial, regulatory and administrative hardships. Insurance and Medicare reimbursements are not keeping up with rising expenses and, as a result, payments are delayed. The first stage HIPAA regulations for patient privacy, information security, and submission practices began taking effect in 2003 and insurance payers have since begun requiring electronic submission of claims. These forces are creating a strong and immediate need to automate data collection during the patient encounter. Accordingly, the market potential is extensive. According to the A.C. Group, a Houston-based market research firm, more than 750,000 physicians practice in the United States. An additional 4 million healthcare professionals support these individuals, most of whom are required to enter extensive patient information, including vital signs, supported diagnosis, follow-up, and submission documentation. It is an expensive and time-consuming process. It is estimated that only 8,000 physicians personally use computer-based technology during the day-to-day patient encounter. External legal and financial pressures have made automation of the patient encounter a necessity, creating a new market estimated to exceed $4.9 billion, only an estimated 18% of which has been penetrated to date. The potential for exponential growth and rapid expansion within the industry is very high, especially for a company such as WiFiMed Holdings which, through our subsidiaries, has already established itself as a leader by providing advanced and innovative technologies.

In terms of financials, we expect our sales and growth rate will drastically increase over the coming years with the addition of the current and future acquisitions. We are working on providing our investors with a gauge of what this growth will be and you will soon be able to read and fully comprehend the level of accelerated top and bottom line growth rate that has all of us internally very excited.

Since we expect 2008 and 2009 to represent significant breakaway years for WiFiMed Holdings, we want to ensure that Wall Street recognizes our growth potential and begins to value us based on it. In an effort to ensure our message is properly communicated, we have recently retained the services of Nexus Investor Relations to help create and implement a strategic investor relations program and provide consulting services on a number of issues pertaining to our public status. Nexus IR has had overwhelming success in helping micro- and small-cap companies increase their exposure to the investment community. We are looking forward to working with Nexus IR in implementing a similar investor relations program for WiFiMed Holdings and recommend that each one of you acquaint yourself with our Nexus IR representative, Zack Noory. He can be reached at 310-606-2018 or via e-mail at znoory@nexusir-online.com.

With these and other actions that I have described here, we have positioned the Company to take advantage of a growing and yet largely untapped market. I believe that the market for our products, both current and future, will continue to expand. This is an excellent time to be in our business and it's a very good time to be an investor in that same space. The entire management team at WiFiMed Holdings puts the highest priority on creating shareholder value. In the coming months and years, we think that focus will produce highly gratifying and profitable results. I thank you for your continued support of WiFiMed Holdings and look forward to updating you again next year with all the accomplishments of 2008.

Sincerely,
Gregory Vacca			Marshall Sterman
Chief Executive Officer			Chairman of the Board

If you would like to be added to WiFiMed Holdings’ investor email list please contact Zack Noory with Nexus Investor Relations at znoory@nexusir-online.com.

About WiFiMed Holdings Company, Inc.

WiFiMed Holdings Company, Inc., through its wholly owned subsidiaries WiFiMed, Inc., EncounterPRO Healthcare Resources, Inc., and CyberMedx Medical Systems, Inc. offers proprietary solutions enabling physicians and other healthcare providers to document the physician-patient encounter through continuously updated state-of-the-art technologies. EncounterPRO Healthcare Resources, Inc’s proprietary product, EncounterPRO^® EHR, was developed to assist physicians and health care providers manage patient workflow. The EncounterPRO EHR gives physicians and staff the most flexible and sophisticated workflow engine available in an EHR. This premier software requires virtually no level of computer literacy and works off touch screens, PC Tablets or a mouse as the primary means of data input. EncounterPRO EHR has been designed to meet the Health Insurance Portability and Accountability Act (HIPAA) requirements and is designed to reduce medical errors, documentation time, overhead, and time spent filing insurance claims. CyberMedx Medical Systems, Inc. developed the InteleNett™ family of patient data management products for the hospital industry and the Cyber Medical Exchange (C_ME™) family of Internet based telemonitoring device data management products for the home care and nursing home industries. These systems increase productivity, reduce cost, improve efficiency, and extend the operational life expectancy of existing patient monitoring and therapy delivery devices. EncounterPRO EHR 5.0 is CCHIT certified for Ambulatory Care 2006. For additional information, please visit www.encounterpro.com.

Forward looking statement: Except for the historical information, the matters discussed in this news release may contain forward-looking statements, including, but not limited to, factors relating to future sales. These forward-looking statements may involve a number of risks and uncertainties. Actual results may vary significantly based on a number of factors, including, but not limited to, uncertainties in product demand, the impact of competitive products and pricing, changing economic conditions around the world, release and sales of new products and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission.